Aetna Inc. Stock
Your prediction
Pros and Cons of Aetna Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Aetna Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Aetna Inc. | - | - | - | - | - | - | - |
| Humana Inc. | -1.180% | 1.198% | -5.056% | 38.072% | 53.916% | -25.583% | -2.901% |
| Cigna Corp. | -1.270% | -1.269% | -7.231% | -4.965% | 2.857% | -9.084% | 35.164% |
| UnitedHealth Group Inc. | -2.420% | -1.363% | -4.822% | 33.641% | 23.983% | -25.290% | 0.000% |
News
Evolent Health Q2 Earnings Call Highlights
Key Points
- Interested in Evolent Health, Inc? Here are five stocks we like better.
- Evolent raised its 2026 outlook after Q2 revenue rose 31% sequentially to $653 million and adjusted EBITDA
CVS Health Q2 Earnings Call Highlights
Key Points
- Interested in CVS Health Corporation? Here are five stocks we like better.
- CVS Health exceeded second-quarter expectations, reporting $106 billion in revenue, adjusted EPS of $2.58
Sight Sciences Q2 Earnings Call Highlights
Key Points
- Interested in Sight Sciences, Inc.? Here are five stocks we like better.
- Second-quarter revenue rose 20% year over year to $23.4 million, driven by 8% growth in interventional